Boston Scientific Corp. (BSX)

38.40
NYSE : Health Technology
Prev Close 38.40
Day Low/High 0.00 / 0.00
52 Wk Low/High 24.54 / 37.92
Avg Volume 6.12M
Exchange NYSE
Shares Outstanding 1.38B
Market Cap 52.23B
EPS 0.10
P/E Ratio 99.39
Div & Yield N.A. (N.A)
Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead

Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead

A bullish market and another quant upgrade could push BSX past our $31 target.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BSX, RMP, TGEN Downgrades: ESCA, VYGR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock

Canaccord is bullish on Edwards Lifescience stock.

Cramer: These Stocks Look Like 'Easy Pickings'

Cramer: These Stocks Look Like 'Easy Pickings'

From Aetna to United Technologies, these names are hot.

Cramer: The Best Performers Show No Signs of Letting Up

Cramer: The Best Performers Show No Signs of Letting Up

Their overseas business has been carrying them.

Boston Scientific Confirms $435 Million Purchase of Swiss Co. Symetis

Boston Scientific Confirms $435 Million Purchase of Swiss Co. Symetis

Symetis is a structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACIW, ACM, BID, CAJ, CHT, GLRE, MBLY, MDXG, UEIC Downgrades: BSX, IAC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Masimo's Stock Is a Great Buy Right Now

Masimo's Stock Is a Great Buy Right Now

This patient-monitoring device-maker has plenty of room for growth.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Boston Scientific Corporation And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Boston Scientific Corporation (" Boston Scientific" or the "Company") (NYSE: BSX) concerning possible violations of federal securities...

The S&P 500 Companies With the Most Diverse Boards

The S&P 500 Companies With the Most Diverse Boards

The most ethnically and gender diverse boards may surprise you.

A Play on Intel's Breakdown

A Play on Intel's Breakdown

With trend favoring the bears, I'm favoring a bearish call spread.

Analysts' Actions -- Chipotle, Disney, Brinker, JPMorgan and More

Analysts' Actions -- Chipotle, Disney, Brinker, JPMorgan and More

Here are Tuesday's top research calls, including upgrades for Disney, Continental Resources and Agios Pharmaceuticals, and downgrades for Chipotle, Brinker International and JPMorgan Chase.

Boston Scientific's Upgrade May Lead to Breakout

Boston Scientific's Upgrade May Lead to Breakout

If BSX shares can rise above $24, it's clear sailing to $31, perhaps as soon as next week.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BSX, FCE.B, TEDU Downgrades: ALOG, CCC, EFII, EZPW, NQ, VSTO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Boston Scientific Charts Appear Boston Strong

Boston Scientific Charts Appear Boston Strong

The technical signs indicate the stage may be set for new highs in the maker of medical devices.

Edwards' Life Goes On Without Big M&A

Edwards' Life Goes On Without Big M&A

As the dominant player in the transcatheter aortic valve replacement market, Edwards doesn't 'need' large deals.

How to Trade Wednesday's Most Active Stocks - Sprint, AMD, ArcelorMittal and More

How to Trade Wednesday's Most Active Stocks - Sprint, AMD, ArcelorMittal and More

Here's a technical look on how to trade some of the most active stocks on the market today.

Analysts' Actions -- Boston Scientific, McDonald's, National Beverage, More

Analysts' Actions -- Boston Scientific, McDonald's, National Beverage, More

Here are Monday's top research calls, including upgrades for McDonald's and National Beverage, and a downgrade for Boston Scientific.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AIT, DSPG, FCAU, FOGO, HFC, KLIC, LINK, MGLN, MOG.A, MOG.B Downgrades: BSX, DOC, FCE.A, FCE.B, ICCC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

The Most Admired Corporate Dealmakers in a Record Year

The Most Admired Corporate Dealmakers in a Record Year

In a record year for acquisitions, 18 companies from across the spectrum were singled out by M&A professionals for doing deals that got results.

Boston Scientific Takes Over #76 Spot From Sherwin-Williams

Boston Scientific Takes Over #76 Spot From Sherwin-Williams

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Boston Scientific Corp. has taken over the #76 spot from Sherwin-Williams Co , according to ETF Channel.

'Mad Money' Lightning Round: Smith and Wesson Represents Value, Cramer Says

'Mad Money' Lightning Round: Smith and Wesson Represents Value, Cramer Says

Jim Cramer likes SWHC and BX, but not NAT and DBD.

Jim Cramer's 'Mad Money' Recap: How Powerful Are GE, Royal Dutch Shell and Occidental?

Jim Cramer's 'Mad Money' Recap: How Powerful Are GE, Royal Dutch Shell and Occidental?

Cramer previews important earnings reports scheduled for the coming week.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARI, BA, BSX, PIH, SCCO, TER, TIF, VLRS Downgrades: AIT, KO, NWSA, POL, PPC, VEC Initiations: SMBK Read on to get TheStreet Quant Ratings' detailed report:

Boston Scientific Shares Flat Following Mixed Earnings Results

Boston Scientific Shares Flat Following Mixed Earnings Results

Boston Scientific reported earnings of $0.27, in-line with analyst expectations.

Boston Scientific (BSX) Stock Advances on Q3 Revenue Beat, Guidance

Boston Scientific (BSX) Stock Advances on Q3 Revenue Beat, Guidance

Boston Scientific (BSX) reported 2016 third-quarter revenue that exceeded analysts' expectations and raised its full-year revenue forecast.

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

The medical devices company is likely to stick to small- to mid- sized M&A unless it finds itself the target.

What to Look for When Boston Scientific (BSX) Reports Q3 Earnings

What to Look for When Boston Scientific (BSX) Reports Q3 Earnings

Before Wednesday's market open Boston Scientific (BSX) will post 2016 third quarter results.

Jim Cramer's 'Mad Money' Recap: Here's What's Important Next Week

Jim Cramer's 'Mad Money' Recap: Here's What's Important Next Week

Cramer will be monitoring earnings and the Federal Reserve next week.

TheStreet Quant Rating: A- (Buy)